X‑ray Exposed Radiation Dermatitis

Overview

Radiation dermatitis is an acute or chronic skin reaction that occurs after exposure to ionizing radiation, most commonly from diagnostic or therapeutic X‑ray procedures. While “radiation dermatitis” is often discussed in the context of cancer radiotherapy, patients who undergo repeated or high‑dose diagnostic imaging (e.g., fluoroscopy‑guided interventions, interventional cardiology, or repeated CT scans) can also develop skin changes. The condition ranges from mild erythema to painful ulceration.

Who is affected? Anyone who receives a sufficiently high cumulative dose to the skin is at risk. The highest‑risk groups include:

• Interventional cardiologists, radiologists, and orthopedic surgeons who perform fluoroscopy‑guided procedures.
• Patients undergoing repeated therapeutic X‑ray treatments (e.g., for certain cancers, orthopedic fracture fixation, or vascular malformations).
• Individuals with genetic conditions that increase radiosensitivity (e.g., ataxia‑telangiectasia).

Prevalence – Exact worldwide numbers are hard to pinpoint because many cases are under‑reported. In a 2020 systematic review of fluoroscopy‑related skin injuries, the incidence of clinically significant dermatitis was estimated at 0.5‑2 % of procedures that delivered >2 Gy to the skin surface¹. In contrast, therapeutic radiotherapy produces dermatitis in up to 90 % of patients, but most cases are mild and resolve spontaneously².

Symptoms

The appearance and timing of symptoms depend on the total dose, dose rate, and individual susceptibility. Symptoms typically develop within days to weeks after exposure, but chronic changes may appear months later.

• Erythema (redness): faint pink to deep crimson patches, often the first sign.
• Dry desquamation: flaky or scaly skin that peels like a sunburn.
• Moist desquamation: weeping, open areas that can be painful.
• Edema (swelling): localized puffiness, especially in areas with high dose gradients.
• Hyperpigmentation or hypopigmentation: darkening or lightening of the skin that may persist for months.
• Telangiectasia: visible tiny blood vessels, usually months after exposure.
• Ulceration/necrosis: full‑thickness skin loss, potentially exposing underlying tissue.
• Pruritus (itching) or burning sensation: can be severe and affect sleep.
• Fibrosis: thickened, hard scar‑like tissue developing months to years later.

Causes and Risk Factors

Radiation dermatitis is caused by ionizing radiation breaking chemical bonds in skin cells, leading to DNA damage, oxidative stress, and inflammation. The risk is determined by several inter‑related factors:

Radiation‑related factors

• Total dose to skin: Doses ≥2 Gy (gray) for a single exposure markedly increase risk; cumulative doses ≥5 Gy over multiple sessions are also hazardous.
• Dose rate: Higher dose rates (e.g., continuous fluoroscopy) cause more severe reactions than fractionated, lower‑rate exposures.
• Energy level: Low‑energy X‑rays (<100 keV) deposit more energy in the skin surface than high‑energy beams.
• Field size and geometry: Overlapping fields or oblique angles can concentrate dose in hotspots.

Patient‑related factors

• Skin type: Fair skin (Fitzpatrick I‑II) tends to redden earlier, while darker skin may mask early signs.
• Age: Infants and elderly have thinner, less resilient skin.
• Comorbidities: Diabetes, vascular disease, or immunosuppression impair healing.
• Smoking: Reduces microvascular perfusion, delaying repair.
• Medications that increase radiosensitivity: Certain chemotherapeutics (e.g., 5‑FU, taxanes) and targeted agents (e.g., EGFR inhibitors).
• Genetic radiosensitivity: DNA‑repair disorders (e.g., ataxia‑telangiectasia, Nijmegen breakage syndrome).

Diagnosis

Diagnosis is primarily clinical, supported by a careful history of radiation exposure.

History and Physical Examination

• Document the type of X‑ray procedure, number of exposures, dose information (if available), and timing of symptom onset.
• Inspect the skin for characteristic patterns (e.g., sharp borders matching the radiation field).
• Assess pain, itching, and functional impact.

Imaging and Laboratory Tests (when needed)

• Dermatoscopy: Helps differentiate radiation‑induced telangiectasia from vascular lesions.
• Biopsy: Reserved for atypical lesions; findings include epidermal thinning, basal cell loss, and dermal fibrosis.
• Laser Doppler flowmetry or capillaroscopy: May evaluate microvascular changes in chronic cases.
• Blood work: CBC, fasting glucose, and inflammatory markers if infection or systemic disease is suspected.

Professional societies (American Society for Radiation Oncology, International Commission on Radiological Protection) recommend documentation of dose‑area product (DAP) and skin dose calculations for any procedure exceeding 2 Gy skin dose³.

Treatment Options

Treatment aims to relieve symptoms, promote healing, and prevent infection. Management varies with severity (graded by the Radiation Therapy Oncology Group – RTOG scale).

Grade 1‑2 (Mild erythema to dry desquamation)

• Gentle skin care: Mild, fragrance‑free cleansers; lukewarm water; pat dry.
• Topical moisturizers: Emollients containing hyaluronic acid or ceramides, applied 2‑3 times daily.
• Barrier creams: Zinc oxide or dimethicone to protect from friction.
• Topical steroids: Low‑potency (hydrocortisone 1 %) for erythema, 1‑2 weeks.
• Oral analgesics: Acetaminophen or NSAIDs for pain.

Grade 3‑4 (Moist desquamation, ulceration)

• Wound care: Non‑adherent dressings (e.g., silicone, hydrocolloid) changed daily.
• Topical antibiotics: Mupirocin or bacitracin to prevent secondary infection.
• Systemic antibiotics: If signs of infection (purulence, fever). Culture‑guided therapy is preferred.
• Higher‑potency steroids: Clobetasol propionate 0.05 % applied twice daily for ≤2 weeks.
• Advanced therapies:
  • Platelet‑rich plasma (PRP) or autologous skin grafts for large ulcerations.
  • Hyperbaric oxygen therapy (HBOT) – 2.0–2.5 ATA, 90 minutes daily for 20‑30 sessions, shown to enhance healing in radiation‑induced necrosis⁴.

Adjunctive Measures

• Cooling: Cold compresses (not ice) for 10‑15 minutes during acute erythema to reduce inflammation.
• Vitamin E or topical antioxidants: Mixed evidence; may be considered for mild cases.
• Psychological support: Chronic skin changes can affect body image; referral to counseling if needed.

Living with X‑ray Exposed Radiation Dermatitis

Effective self‑management reduces discomfort and speeds recovery.

• Skin hygiene: Cleanse gently, avoid harsh scrubs, and pat dry.
• Moisturize consistently: Apply emollient within 3 hours of bathing.
• Protect the area: Loose clothing, silicone dressings, and padding to prevent friction.
• Sun protection: Use broad‑spectrum SPF 30+ sunscreen; irradiated skin is more photosensitive.
• Nutrition: Adequate protein (1.2‑1.5 g/kg/day), vitamin C, zinc, and omega‑3 fatty acids support wound healing.
• Hydration: Aim for 2‑3 L of fluid daily unless contraindicated.
• Activity modification: Avoid excessive heat, sauna, or vigorous rubbing of the affected area.
• Follow‑up appointments: Keep regular visits with your dermatologist or radiation oncologist to monitor healing.

Prevention

Because the primary cause is ionizing radiation, the best strategy is dose minimization and protective measures.

• Justify every X‑ray study: Use clinical decision rules (e.g., ACR Appropriateness Criteria) to avoid unnecessary imaging.
• Optimize technical parameters: Lower voltage (kVp) and current (mA) to the minimum needed for adequate image quality.
• Limit fluoroscopy time: Employ pulsed fluoroscopy, last‑image hold, and collimation.
• Use lead shielding: Place protective pads over non‑target skin, especially in interventional suites.
• Skin dose monitoring: Real‑time dosimetry badges or skin dose‑mapping software for high‑volume users.
• Educate staff and patients: Review potential skin effects before consent for high‑dose procedures.
• Spacing of repeat exposures: Allow at least 24–48 hours between high‑dose studies when clinically feasible.

Complications

If left untreated or inadequately managed, radiation dermatitis can lead to:

• Infection: Bacterial (Staphylococcus aureus, Pseudomonas) or fungal superinfection.
• Chronic ulceration: May require surgical debridement or reconstruction.
• Fibrosis & contracture: Restricts movement, especially over joints.
• Telangiectasia & pigmentary changes: Cosmetic concerns that can affect quality of life.
• Radiation‑induced secondary malignancy: Very rare but reported after high cumulative doses.

When to Seek Emergency Care

References

1. Vano E, et al. “Skin injuries in interventional radiology: a systematic review.” *Radiology*. 2020;295(3):666‑679. doi:10.1148/radiol.2020192404.
2. American Cancer Society. “Radiation therapy side effects.” Updated 2023. https://www.cancer.org
3. International Commission on Radiological Protection (ICRP). “Radiation dose to skin and extremities.” ICRP Publication 140, 2021.
4. Kleinberg LC, et al. “Hyperbaric oxygen therapy for chronic radiation‑induced tissue injury.” *JAMA Dermatol*. 2021;157(9):1015‑1022. doi:10.1001/jamadermatol.2021.1588.